| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/26/2009 | CN101513391A Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 08/26/2009 | CN100531799C Preparation for enhancement of action of anti-infective agent and method |
| 08/26/2009 | CN100531798C Combination therapies for B-cell lynphomas comprising administration of anti-CD20 antibody |
| 08/26/2009 | CN100531796C FGFR agonists |
| 08/26/2009 | CN100531728C Use of neuron sodium ion pass antagonist for controlling homothermal animal ectoparasite |
| 08/26/2009 | CN100531719C Slow-released injection containing methotrexate synergist |
| 08/26/2009 | CN100531718C Slow-released injection containing methotrexate synergist |
| 08/26/2009 | CN100531717C Slow-released anticancer preparation containing methotrexate |
| 08/26/2009 | CN100531716C Slow-released injection containing methotrexate and its synergist |
| 08/26/2009 | CN100531715C Slow-released methotrexate injection |
| 08/25/2009 | US7579479 Modulators of blood glucose levels, triglyceride levels, insulin levels and non-esterified fatty acid (NEFA) levels; hypoglycemia |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579355 Inhibitors of Akt activity |
| 08/25/2009 | US7579331 Method of improved diuresis in individuals with impaired renal function |
| 08/25/2009 | US7579327 Isolated polynucleotide sequences; controlling neovasculization; cell growth regulators |
| 08/25/2009 | US7579026 A combination of Bacopa monniera extract, milk thistle extract, ashwagandha powder, green tea extract, and turmeric extract increases the enzyme activity level of superoxide dismutase and catalase and decreases the plasma concentration level of thiobarbituric acid reactive chemical species |
| 08/25/2009 | US7579006 Method of treating immune pathologies with low dose estrogen |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | US7578784 Cardiac support device with differential expansion |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/20/2009 | WO2009103093A1 Use of aloe vera for increasing the bioavailability of poorly absorbable medicinal drugs |
| 08/20/2009 | WO2009103053A1 Fluoroquinolone derivatives for ophthalmic applications |
| 08/20/2009 | WO2009102986A1 Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox1 inhibitor |
| 08/20/2009 | WO2009102962A2 Combination of alpha 7 nicotinic agonists and antipsychotics |
| 08/20/2009 | WO2009102467A2 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | WO2009101942A1 Screening method |
| 08/20/2009 | WO2008148873A3 Hydroxyproline compositions and uses thereof |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209902 Kit for adminstering a therapeutic agent into tissue |
| 08/20/2009 | US20090209901 Apparatus for adminstering a therapeutic agent into tissue |
| 08/20/2009 | US20090209658 Embolic compositions |
| 08/20/2009 | US20090209562 Fused ring 4-oxopyrimidine derivative |
| 08/20/2009 | US20090209535 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/20/2009 | US20090209495 Use of edg receptor binding agents in cancer |
| 08/20/2009 | US20090209493 Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor |
| 08/20/2009 | US20090209461 Modification of feeding behavior |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208969 Polynucleotides and Polypeptides Encoding Receptors |
| 08/20/2009 | US20090208581 Formulations limiting spread of pulmonary infections |
| 08/20/2009 | US20090208524 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 08/20/2009 | US20090208512 Catalytic anti-factor VIII allo-antibodies |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208483 Antibody selective for dr4 and uses thereof |
| 08/20/2009 | US20090208468 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| 08/20/2009 | US20090208459 Methods of treating anemia using recombinant adeno-associated virus virions |
| 08/20/2009 | US20090207970 Methods and Devices for Quantitative Analysis of X-Ray Images |
| 08/20/2009 | DE102008010363A1 Sgk1 als therapeutisches und diagnostisches Target für karzinomatöse Erkrankungen Sgk1 as therapeutic and diagnostic target for cancerous diseases |
| 08/20/2009 | DE102008010362A1 Sgk1 als therapeutisches und diagnostisches Target für virale Erkrankungen Sgk1 as therapeutic and diagnostic target for viral diseases |
| 08/20/2009 | CA2726861A1 Devices, formulations, and methods for delivery of multiple beneficial agents |
| 08/20/2009 | CA2715460A1 Continuous cell programming devices |
| 08/20/2009 | CA2715268A1 Alpha 7 nicotinic agonists and antipsychotics |
| 08/20/2009 | CA2714580A1 Fluoroquinolone derivatives for ophthalmic applications |
| 08/19/2009 | EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090583A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2009 | EP2090321A1 Health restorer comprising ascorbic acid, lactic acid, a pyruvate and magnesium oxide |
| 08/19/2009 | EP2090315A1 Method and system for producing medicinal alcohol as a prophylatic or remedy for cancer, HIV, AIDS and autoimmune diseases |
| 08/19/2009 | EP2090312A1 (S,S) reboxetine for treating attention deficit disorder |
| 08/19/2009 | EP2090304A2 Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases |
| 08/19/2009 | EP2089046A2 Antidiabetogenic calcium-peptide composition |
| 08/19/2009 | EP2089037A2 Mixture and method for reducing cholesterol using hydrophobic microparticles |
| 08/19/2009 | EP2089022A2 Composition containing a mixture of antidepressants for treating premature ejaculation |
| 08/19/2009 | EP2089016A2 Method for treatment of macular degeneration |
| 08/19/2009 | EP2089013A1 Acetaminophen / ibuprofen combinations |
| 08/19/2009 | EP1641453B1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | EP1187918B9 Tek antagonists |
| 08/19/2009 | CN101511388A Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 08/19/2009 | CN101511372A Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent |
| 08/19/2009 | CN101511365A Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor |
| 08/19/2009 | CN101511344A Oral pharmaceutical composition of a poorly water-soluble active substance. |
| 08/19/2009 | CN101507811A Wound healing agent and composition |
| 08/19/2009 | CN101507717A Composite tablet capable of treating peptic ulcer and preparation method thereof |
| 08/19/2009 | CN101507708A Preparation method of liposome |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100528850C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 08/19/2009 | CN100528238C Oral DNA combination for treating chronic infection of hepatitis B virus |
| 08/19/2009 | CN100528231C Anti-inflammatory and antimicrobial uses for bioactive glass compositions |
| 08/19/2009 | CN100528230C Recombination human MUC1-MBP fusion protein antitumour vaccine and production technology |
| 08/19/2009 | CN100528173C 4'-substituted nucleosides |
| 08/19/2009 | CN100528159C Nicotinic receptor agonists for treatment of inflammatory diseases |
| 08/19/2009 | CN100528156C Prevention of addiction in pain management |
| 08/19/2009 | CN100528149C A composition for treating neurocerebrovascular disorders |
| 08/18/2009 | US7576255 Silver-containing compositions, devices, and methods for making |
| 08/18/2009 | US7576200 Diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 08/18/2009 | US7576178 DADD, death activator death domain protein |
| 08/18/2009 | US7576177 Heat shock proteins (HSP) activate lymphocytes to produce immunomodulatory cytokines and influence cytokines, chemokines, and surface antigens; drug screening |
| 08/18/2009 | US7576175 Alpha-4 beta-1 integrin ligands for imaging and therapy |
| 08/18/2009 | US7576131 Administering 2-acetamidoethyl 4-chlorophenyl-(3-trifluoro-methylphenoxy)acetate, as antidiabetic agents |
| 08/18/2009 | US7576101 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576066 Administering nucleic acid to stimunlate immunology response |
| 08/18/2009 | US7575879 Bone morpogenic proteins; endothelial growth factor e (vegfe); wound healing agents; bradycardial agents; identification and preparation of vascular endothelial growth factor-E (VEGF-E), a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1 |